Importer of Controlled Substances Registration: Mylan Technologies, Inc., 52762-52763 [2014-21052]
Download as PDF
<![CDATA[
52762
Federal Register / Vol. 79, No. 171 / Thursday, September 4, 2014 / Notices
Procedures and Penalties Act, 15 U.S.C. § 16,
including making copies available to the
public of this Final Judgment, the
Competitive Impact Statement, and any
comments thereon and the United States’s
responses to comments. Based upon the
record before the Court, which includes the
Competitive Impact Statement and any
comments and response to comments filed
with the Court, entry of this Final Judgment
is in the public interest.
Date: llllllllllllllllll
Court approval subject to procedures of
Antitrust Procedures and Penalties Act, 15
U.S.C. § 16.
lllllllllllllllllllll
United States District Judge
[FR Doc. 2014–21102 Filed 9–3–14; 8:45 am]
BILLING CODE 4410–11–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Fisher Clinical Services,
Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before October 6, 2014. Such persons
may also file a written request for a
hearing on the application pursuant to
21 CFR 1301.43 on or before October 6,
2014.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of importers,
of controlled substances (other than
final orders in connection with
suspension, denial, or revocation of
registration) has been redelegated to the
Deputy Assistant Administrator of the
DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
mstockstill on DSK4VPTVN1PROD with NOTICES
DATES:
VerDate Mar<15>2010
18:14 Sep 03, 2014
Jkt 232001
pursuant to section 7 of 28 CFR pt. 0,
subpt. R, App.
In accordance with 21 CFR
1301.34(a), this is notice that on
December 13, 2013, Fisher Clinical
Services, Inc., 700A–C Nestle Way,
Breinigsville, Pennsylvania 18031–1522
applied to be registered as an importer
of the following basic classes of
controlled substances:
Controlled substance
Methylphenidate (1724) ................
Levorphanol (9220) ......................
Noroxymorphone (9668) ..............
Tapentadol (9780) ........................
Schedule
II
II
II
II
The company plans to import the
listed substances for analytical research
and testing and clinical trials. This
authorization does not extend to the
import of a finished FDA approved or
non-approved dosage form for
commercial distribution in the United
States.
The company plans to import an
intermediate form of Tapentadol (9780)
to bulk manufacture Tapentadol for
distribution to its customers.
Dated: August 27, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–21056 Filed 9–3–14; 8:45 am]
Administration, Attention: Hearing
Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152. Comments
and request for hearings on applications
to import narcotic raw material are not
appropriate. 72 FR 3417 (January 25,
2007).
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of importers
of controlled substances (other than
final orders in connection with
suspension, denial, or revocation of
registration) has been redelegated to the
Deputy Assistant Administrator of the
DEA Office of Diversion Control
(‘‘Deputy Assistant Administrator’’)
pursuant to section 7 of 28 CFR pt. 0,
subpt. R, App.
In accordance with 21 CFR
1301.34(a), this is notice that on July 3,
2014, Cody Laboratories, Inc., 601
Yellowstone Avenue, Cody, Wyoming
82414–9321, applied to be registered as
an importer of the following basic
classes of controlled substances:
SUPPLEMENTARY INFORMATION:
BILLING CODE 4410–09–P
Controlled substance
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Cody Laboratories, Inc.
ACTION:
Notice of application.
On July 3, 2014, Cody
Laboratories, Inc., Cody, Wyoming,
applied to be registered as an importer
of basic classes of controlled substances.
DATES: Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before October 6, 2014. Such persons
may also file a written request for a
hearing on the application pursuant to
21 CFR 1301.43 on or before October 6,
2014.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152. Request for hearings should be
sent to: Drug Enforcement
SUMMARY:
PO 00000
Frm 00138
Fmt 4703
Sfmt 4703
Phenylacetone (8501) ..................
Poppy Straw Concentrate (9670)
Tapentadol (9780) ........................
Schedule
II
II
II
The company plans to import narcotic
raw materials for manufacturing and
further distribution to its customers.
The company is registered with the DEA
as a manufacturer of several controlled
substances that are manufactured from
poppy straw concentrate.
The company plans to import an
intermediate form of tapentadol (9780),
to bulk manufacture tapentadol for
distribution to its customers.
Dated: August 27, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–21058 Filed 9–3–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Registration: Mylan Technologies, Inc.
ACTION:
E:\FR\FM\04SEN1.SGM
Notice of registration.
04SEN1
52763
Federal Register / Vol. 79, No. 171 / Thursday, September 4, 2014 / Notices
Mylan Technologies, Inc.,
applied to be registered as an importer
of certain basic classes of controlled
substances. The DEA grants Mylan
Technologies, Inc., registration as an
importer of those controlled substances.
SUMMARY:
By notice
dated May 28, 2014, and published in
the Federal Register on June 4, 2014, 79
FR 32316, Mylan Technologies, Inc.,
110 Lake Street, Saint Albans, Vermont
05478, applied to be registered as an
importer of certain basic classes of
controlled substances. No comments or
objections were submitted for this
notice.
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the
registration of Mylan Technologies, Inc.,
to import the basic classes of controlled
substances is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971. The DEA investigated the
company’s maintenance of effective
controls against diversion by inspecting
and testing the company’s physical
security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above named
company is granted registration as an
importer of the basic classes of
controlled substances listed:
SUPPLEMENTARY INFORMATION:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
[Docket No. DEA–392]
[Docket No. DEA–392]
Importer of Controlled Substances
Registration: Arizona Department of
Corrections, Aspc-Florence
Importer of Controlled Substances
Registration: Wildlife Laboratories, Inc.
ACTION:
ACTION:
Notice of registration.
Arizona Department of
Corrections, ASPC-Florence applied to
be registered as an importer of a certain
basic class of controlled substance. The
DEA grants Arizona Department of
Corrections, ASPC-Florence registration
as an importer of this controlled
substance.
SUMMARY:
Notice of registration.
Wildlife Laboratories, Inc.,
applied to be registered as an importer
of certain basic classes of controlled
substances. The DEA grants Wildlife
Laboratories, Inc., registration as an
importer of those controlled substances.
SUMMARY:
By notice
dated May 28, 2014, and published in
the Federal Register on June 4, 2014, FR
79 32318, Wildlife Laboratories, Inc.,
1230 West Ash Street, Suite D, Windsor,
Colorado 80550, applied to be registered
as an importer of certain basic classes of
controlled substances. No comments or
objections were submitted for this
notice.
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the
registration of Wildlife Laboratories,
Inc., to import the basic classes of
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verifying the
company’s compliance with state and
local laws, and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of the basic classes of
controlled substances:
SUPPLEMENTARY INFORMATION:
II
II
The company plans to import the
listed controlled substances in finished
dosage form (FDF) from foreign sources
for analytical testing and clinical trials
in which the foreign FDF will be
compared to the company’s own
domestically-manufactured FDF. This
analysis is required to allow the
company to export domesticallymanufactured FDF to foreign markets.
Dated: August 27, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–21052 Filed 9–3–14; 8:45 am]
BILLING CODE 4410–09–P
VerDate Mar<15>2010
18:14 Sep 03, 2014
Jkt 232001
Dated: August 27, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–21087 Filed 9–3–14; 8:45 am]
BILLING CODE 4410–09–P
Methylphenidate (1724) ................
Fentanyl (9801) ............................
The company plans to import the
listed controlled substances for sale to
its customers.
Dated: August 27, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
Schedule
By notice
dated May 28, 2014, and published in
the Federal Register on June 4, 2014, 79
FR 32317, Arizona Department of
Corrections, ASPC-Florence, 1305 E.
Butte Avenue, Florence, Arizona 85132,
applied to be registered as an importer
of a certain basic class of controlled
substance. No comments or objections
were submitted for this notice.
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823, 952(a) and
958(a) and determined that the
registration of Arizona Department of
Corrections, ASPC-Florence to import
the basic class of controlled substance is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated the company’s
maintenance of effective controls
against diversion by inspecting and
testing the company’s physical security
systems, verifying the company’s
compliance with state and local laws,
and reviewing the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above-named
company is granted registration as an
importer of Pentobarbital (2270), a basic
class of controlled substance listed in
schedule II.
The facility intends to import the
above listed controlled substance for
legitimate use. Supplies of this
particular controlled substance are
inadequate and are not available in the
form needed within the current
domestic supply of the United States.
[FR Doc. 2014–21083 Filed 9–3–14; 8:45 am]
Controlled substance
mstockstill on DSK4VPTVN1PROD with NOTICES
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00139
Fmt 4703
Sfmt 9990
Controlled substance
Etorphine (except HCI) (9056)
Etorphine HCI (9059) ..............
E:\FR\FM\04SEN1.SGM
04SEN1
Schedule
I
II
]]>Agencies
[Federal Register Volume 79, Number 171 (Thursday, September 4, 2014)]
[Notices]
[Pages 52762-52763]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-21052]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration: Mylan
Technologies, Inc.
ACTION: Notice of registration.
-----------------------------------------------------------------------
[[Page 52763]]
SUMMARY: Mylan Technologies, Inc., applied to be registered as an
importer of certain basic classes of controlled substances. The DEA
grants Mylan Technologies, Inc., registration as an importer of those
controlled substances.
SUPPLEMENTARY INFORMATION: By notice dated May 28, 2014, and published
in the Federal Register on June 4, 2014, 79 FR 32316, Mylan
Technologies, Inc., 110 Lake Street, Saint Albans, Vermont 05478,
applied to be registered as an importer of certain basic classes of
controlled substances. No comments or objections were submitted for
this notice.
The Drug Enforcement Administration (DEA) has considered the
factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the
registration of Mylan Technologies, Inc., to import the basic classes
of controlled substances is consistent with the public interest and
with United States obligations under international treaties,
conventions, or protocols in effect on May 1, 1971. The DEA
investigated the company's maintenance of effective controls against
diversion by inspecting and testing the company's physical security
systems, verifying the company's compliance with state and local laws,
and reviewing the company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above named company is granted
registration as an importer of the basic classes of controlled
substances listed:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Methylphenidate (1724)..................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to import the listed controlled substances in
finished dosage form (FDF) from foreign sources for analytical testing
and clinical trials in which the foreign FDF will be compared to the
company's own domestically-manufactured FDF. This analysis is required
to allow the company to export domestically-manufactured FDF to foreign
markets.
Dated: August 27, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-21052 Filed 9-3-14; 8:45 am]
BILLING CODE 4410-09-P
